Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

In the latest quarter, 4 analysts provided ratings for Omnicell OMCL, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the ...

Omnicell (OMCL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

Omnicell stock opened at $36.99 on Thursday. The stock has a market cap of $1.73 billion, a P/E ratio of 137.01, a price-to-earnings-growth ratio of 7.53 and a beta of 0.85. The company has a ...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...

FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Thursday reported fourth-quarter profit of $15.8 million. On a per-share basis, the Fort Worth, Texas-based company ...

Importantly, our data indicates that Omnicell's profit was reduced by US$9.9m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits ...